minding memory Articles
Minding Memory
Healthcare at Home for People Living with Dementia
This week we feature a recent study by Katherine Ornstein and colleagues that was published in the Journal of the American Geriatrics Society. Dr. Ornstein studies family caregiving and the home-based clinical care. The study used Medicare claims linked to the National Health and Aging Trends Study to estimate the degree to which people living with dementia use health services from home. We’ll discuss what exactly home-based health services are (and how they are typically categorized) and discuss the role these services are expected to play for people living with dementia.
Minding Memory
Cognitive Impairment and Susceptibility to Scams
For older adults living with dementia, cognitive impairment can lead to susceptibility to fraudulent activities. In this episode we’ll discuss with Dr. Duke Han from the Keck School of Medicine at USC what’s known about the intersection of aging, cognition, and susceptibility to scams.
Minding Memory
Dementia as a Cause of Death
Causes of death were reclassified by the CDC to include contributing factors such as dementia. These changes resulted in dementia jumping up from the 8th cause of death in 2000 to the 6th cause of death in 2018 (and the 5th cause of death among older adults). In this episode we’ll talk with Dr. Bryan James from Rush University about dementia as a cause of death (versus contributing factor).
Minding Memory
The Study Most Often Cited in the First Sentence of Dementia Research Papers
If you’re new to dementia research, you’ll soon come to find that most research papers on dementia start off something like this: “In the United States there are 5.8 million individuals living with dementia and this is expected to increase to 13 million by 2015. . . .” In this episode we discuss the study on dementia prevalence that has been cited thousands of times with one of the authors. Dr. Jennifer Weuve from Boston University joins us today. We also talk more broadly about what makes a research paper highly citable in general.
Minding Memory
What is it Like to be a Caregiver for a Person Living with Dementia?
In our last episode we talked about caregivers for individuals living with dementia. In this second part of our series on caregivers we’ll get to know someone with lived experience. We’re joined in this episode by Peggy Arden whose husband has Alzheimer’s disease. Peggy has graciously agreed to offer us a behind the scenes look at the ups and downs of being a dementia caregiver.
Minding Memory
Caregiving for Individuals Living with Dementia
Individuals living with dementia require care that is often delivered by family and friends. This episode is devoted to discussing some of the unique aspects of dementia caregiving. Our guest today is Dr. Amanda Leggett. Dr. Leggett is a Research Assistant Professor in the Department of Psychiatry here at the University of Michigan. Her research, funded by the National Institutes of Health, is focused on issues related to dementia caregiving. She has interviewed over a hundred patients with dementia and their caregivers.
Minding Memory
Donovan Takes the Telephone Interview for Cognitive Status
One of the richest data sources available to study cognition and aging is the Health and Retirement Study (HRS). This nationally representative survey includes questions to help assess cognition, but many researchers may use this data without actually knowing the questions behind the variables—don’t be That Guy! (or Gal!) Listen to Dr. Lindsay Ryan, an HRS team member, coach Matt as he administers the Telephone Interview for Cognitive Status (TICS) to Donovan, who is surprisingly good at recalling types of birds.
Minding Memory
Drugs and Dementia: The Good, the Bad, and the Ugly
While there are some FDA-approved medications for dementia, more individuals living with dementia are actually prescribed psychotropic medications. In this episode, Donovan introduces Matt to the concept of the behavioral and psychological symptoms of dementia, which are just as much part of dementia as the memory loss—and are probably a big reason for all this other prescribing.
Minding Memory
Keep it Down out There: You’re Hurting my Brain
Our guest in this episode is Dr. Sara Adar. She is an associate professor at the University of Michigan School of Public Health in the department of epidemiology. Dr. Adar was the senior author on a study titled “Long-term community noise exposure in relation to dementia, cognition, and cognitive decline in older adults” that was published in the journal Alzheimer’s & Dementia. The study used data from the Chicago Health and Aging Project to examine the association between exposure to community noise and cognitive impairment. We talk with her about how exposure to noise affects cognition.
Minding Memory
What are the Different Types of Dementia? A Primer for those of us who aren’t Healthcare Clinicians
Often research studies consider dementia as either present or absent, while others specify particular types of dementia. For example, what exactly is frontotemporal dementia? In this episode, we talk with Dr. Henry (Hank) Paulson, who directs the Michigan Alzheimer’s Disease Center, to introduce listeners to the most common types of dementia and hear about some of their defining features. For those of you without clinical backgrounds, consider this your crash course on the types of dementia.
Minding Memory
What are the Implications of the Approval of Aduhelm (Aducanumab) to the US Healthcare System?
In this episode we continue our discussion of the implications of the approval of Aducanumab. Our guest this week is Professor Nicholas Bagley. Prof. Bagley is a professor of law at the University of Michigan Law School and a contributing writer to the Atlantic. Recently he wrote an article titled “The Drug that Could Break American Health Care” that discusses some of the broader (unintended) consequences of the approval of Aducanumab. In this episode we discuss some of the broader cost implications of the new drug.
Minding Memory
Could the FDA’s Approval of a New Drug to Treat Alzheimer’s Disease do More Harm than Good?
Aducanumab is a new drug designed to remove amyloid in the brain. Following an accelerated process, the Food and Drug Administration approved Aducanumab as a treatment for Alzheimer’s disease despite (what many experts feel) little evidence of effectiveness. In this episode we discuss the approval of Aducanumab with Dr. Jason Karlawish from the University of Pennsylvania and talk about what it could mean for drug discovery going forward.
Minding Memory
What is the Value of Early Detection of Dementia?
In this episode we talk with Dr. Ken Langa about the implications of identification of “preclinical” Alzheimer’s disease (situations where individuals may have biological signs of Alzheimer’s but no symptoms). Ken is a leading dementia researcher and our discussion focuses on an article he published called “Preclinical Alzheimer Disease – Early Diagnosis or Overdiagnosis” that was published in JAMA Internal Medicine. In his article co-authored with Dr. Jim Burke, he brings up some of the potential indirect effects of early detection.
Minding Memory
Introduction to the Minding Memory Podcast
In this episode we introduce ourselves and provide an overview of the Minding Memory Podcast. This podcast is supported by the Center to Accelerate Population Research in Alzheimer’s (CAPRA) at the University of Michigan. Our guest this week is Dr. Julie Bynum. Julie is the director of CAPRA and we talk briefly about what the NIH-funded research center is and how to get involved.
